Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer

International Journal of Gynecological Cancer

Volumn 14, Issue 5, 2004, Pages 903-910

  Yang, H J ^a   Liu, Vincent W S ^a   Tsang, P C K ^a   Yip, A M W ^a   Tam, K F ^a   Wong, L C ^a   Ng, T Y ^a   Ngan, H Y S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cervical cancer; Human papillomavirus; Plasma DNA; Quantitative PCR

Indexed keywords

CISPLATIN; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA DETERMINATION; DNA EXTRACTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS STRAIN; VIRUS VIRULENCE; WART VIRUS;

ADULT; AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 4544331720     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891X.2004.014528.x     Document Type: Article

References (27)

1. Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev 1994;3:67-71.
2. Usadel H, Brabender J, Danenberg KD et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-5.
3. Shao ZM, Wu J, Shen ZZ, Nguyen M. p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Clin Cancer Res 2001;7:2222-7.
4. Taback B, Giuliano AE, Hansen NM, Hoon DS. Microsatellite alterations detected in the serum of early stage breast cancer patients. Ann N Y Acad Sci 2001;945:22-30.
5. Utting M, Werner W, Muller G, Schubert J, Junker K. A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood. Ann N Y Acad Sci 2001;945:31-5.
6. Wong IH, Lo YM, Johnson PJ. Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring. Ann N Y Acad Sci 2001;945:36-50.
7. Anker P, Lyautey J, Lederrey C, Stroun M. Circulating nucleic acids in plasma or serum. Clin Chim Acta 2001;313:143-6.
8. Lo YM. Circulating nucleic acids in plasma and serum: an overview. Ann N Y Acad Sci 2001;945:1-7.
9. Lo YM, Chan LY, Lo KW et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999;59:1188-91.
10. Lo YM, Chan LY, Chan AT et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999;59:5452-5.
11. Lo YM. Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring. Ann N Y Acad Sci 2001;945:68-72.
12. Lo YM, Chan AT, Chan LY et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 2000;60:6878-81.
13. Lo YM, Leung SF, Chan LY et al. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res 2000;60:2351-5.
14. Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996;334:1030-8.
15. Furumoto H, Irahara M. Human papilloma virus (HPV) and cervical cancer. J Med Invest 2002;49:124-33.
16. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer 1999;80:2008-18.
17. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
18. Einstein MH, Goldberg GL. Human papillomavirus and cervical neoplasia. Cancer Invest 2002;20:1080-5.
19. Liu VW, Tsang P, Yip A, Ng TY, Wong LC, Ngan HY. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients. Gynecol Oncol 2001;82:269-72.
20. Duenas A, Lizano M, Carrillo AL, Wojcik J, Trejo C. DNA of human papillomavirus detected by PCR in plasma of cervical cancer patients: a potential marker of residual disease. Clin Chem 2001;47:361-70 (Abstracts).
21. Pornthanakasem W, Shotelersuk K, Termrungruanglert W, Voravud N, Niruthisard S, Mutirangura A. Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer 2001;1:2.
22. Dong SM, Pai SI, Rha SH et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev 2002;11:3-6.
23. Mincheva A, Gissmann L, zur Hausen HH. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (Berl) 1987;176:245-56.
24. Capone RB, Pai SI, Koch WM et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 2000;6:4171-5.
25. Giuliano AR, Harris R, Sedjo RL et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 2002;186:462-9.
26. Swan DC, Tucker RA, Tortolero-Luna G et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999;37:1030-4.
27. Ylitalo N, Sorensen P, Josefsson AM et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2194-8.